Royal Bank Of Canada Catalyst Biosciences, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.33 - $0.65 $83 - $164	253 New	253 $0
Q1 2023 May 15, 2023	BUY	$0.19 - $0.64 $1 - $3	6 Added 150.0%	10 $0
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.57 $1 - $2	4 New	4 $0
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $8,217 - $11,261	-2,174 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.1 - $5.33 $8,913 - $11,587	2,174 New	2,174 $9,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.